Nektar Therapeutics (NKTR)
Jun 20 4:00pm Add NKTR to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
NKTR News Stream
All News Types
Commentary Corp. News Cramer Downgrade Earnings Hedge Fund Mgmt Change New Coverage (Bullish) New Coverage (Neutral) Options Product News PT Lowered PT Raised PT Set (Bullish) PT Set (Neutral) Rating Reiterated (Bullish) Resumes Coverage (Bullish) Rumor Stock Offering
Loading, please wait...
View All NKTR News
Nektar Therapeutics (NKTR) Company Bio
Nektar Therapeutics is a biopharmaceutical company, developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives, and immunology.
NKTR Price/Volume Stats
Page generated in 0.4326 seconds.